Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job Schippers, Patrick Smeele, Sara Azhang, Imke Bartelink, Pierre Bet, Wim Boersma, Karin Boomars, Peter Bonta, Lieuwe Bos, Job Van Bragt, Gert-Jan Braunstahl, Lucas Celant, Katrien Eger, Miranda Geelhoed, Yurika Van Glabbeek, Hans GrotjohanShow lessLaura Hagens, Chris Happe, Leo Heunks, Michel Van Den Heuvel, Wouter Hoefsloot, Rianne Hoek,

Journal title: European Respiratory Journal

Journal publisher: European Respiratory Society

Published year: 2021

DOI identifier: 10.1183/13993003.congress-2021.oa4119